← Back to news
NewsIMMUNOMETABOLISM (COBHAM, SURREY)Friday, March 6, 2026 · March 6, 2026

From lipid switch to tissue repair: how resolvins reprogram macrophage polarization and function.

WHY IT MATTERS

Recent peer-reviewed research on Duchenne muscular dystrophy that may be relevant for patients and caregivers.

Specialized pro-resolving mediators (SPMs) derived from docosahexaenoic acid (DHA), particularly D-series resolvins (RvD1, RvD2, RvD3, and RvD5), function to terminate inflammation while preserving host defense. They are synthesized from DHA by lipoxygenases and act through G‑protein‑c...

Read on PubMed
Read the original at Immunometabolism (Cobham, Surrey)
ResearchPubMedDuchenne muscular dystrophy

Related conditions

Duchenne muscular dystrophy

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.